AKT1 and non-small cell lung carcinoma: GSDMD was found to be upregulated in non-small cell lung cancer (NSCLC), knockdown of GSDMD attenuated tumor proliferation by promoting apoptosis and inhibiting EGFR/Akt signaling in NSCLC (204).